Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials | Science Translational Medicine

Skip to main content

Article Information

vol. 10 no. 422

DOI:

https://doi.org/10.1126/scitranslmed.aao0475

PubMed:

Published By:

American Association for the Advancement of Science

Print ISSN:

Online ISSN:

History:

Received for publication June 12, 2017
Accepted for publication December 8, 2017

Copyright & Usage:

Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works http://www.sciencemag.org/about/science-licenses-journal-article-reuseThis is an article distributed under the terms of the Science Journals Default License.

Author Information

Marsha C. Lampi¹ and
Cynthia A. Reinhart-King²,*

¹Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14850, USA.
²Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212, USA.

↵*Corresponding author. Email: cynthia.reinhart-king{at}vanderbilt.edu

Altmetric

Article usage

Article usage: December 2017 to April 2019

	Abstract	Full	Pdf
Dec 2017	1	2	1
Jan 2018	5798	512	1046
Feb 2018	517	92	174
Mar 2018	499	89	140
Apr 2018	420	68	117
May 2018	455	79	111
Jun 2018	366	55	77
Jul 2018	270	76	68
Aug 2018	441	179	101
Sep 2018	290	154	80
Oct 2018	386	229	141
Nov 2018	311	170	113
Dec 2018	316	145	81
Jan 2019	332	561	457
Feb 2019	427	468	345
Mar 2019	438	408	287
Apr 2019	293	406	264

Science Translational Medicine: 10 (422)

Science Translational Medicine

Vol 10, Issue 422
03 January 2018

Table of Contents

Article Tools

Email

Thank you for your interest in spreading the word about Science Translational Medicine.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email

Your Name

Send To
Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials

Message Subject (Your Name) has forwarded a page to you from Science Translational Medicine

Message Body (Your Name) thought you would like to see this page from the Science Translational Medicine web site.

Your Personal Message
Download Powerpoint
Print
Save to my folders

Log In with your AAAS Login
Alerts

Please log in to add an alert for this article.

Log In with your AAAS Login

Sign In to Email Alerts with your Email Address
Email
Citation tools
Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials

By Marsha C. Lampi, Cynthia A. Reinhart-King

Science Translational Medicine03 Jan 2018

Targeting extracellular matrix stiffness holds clinical potential to attenuate pathological progression in the emerging field of mechanomedicine.

Citation Manager Formats

BibTeX

Bookends

EasyBib

EndNote (tagged)

EndNote 8 (xml)

Medlars

Mendeley

Papers

RefWorks Tagged

Ref Manager

RIS

Zotero
Share

Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials

By Marsha C. Lampi, Cynthia A. Reinhart-King

Science Translational Medicine03 Jan 2018

Targeting extracellular matrix stiffness holds clinical potential to attenuate pathological progression in the emerging field of mechanomedicine.

Share This Article:

Citing Articles in: